Latest HPV vaccine Stories
LONDON, June 6, 2011 /PRNewswire/ -- - Launch of 'my diary from down under' by Nikki Bayley In the UK, 20 per cent of women still do not attend smear tests, putting themselves at risk of leaving pre-cancerous cervical cells undetected[i].
Results of a Chinese study showed that the HPV vaccine did not have significant effects on the number of disease flares or antibody measures in patients with inactive SLE receiving stable doses of medications after administration, and therefore was determined safe to use to prevent HPV in this group of patients.
Researchers have found that a test for HPV is better than a pap smear for predicting cervical cancer risk for women over 30, while a single PSA for men in their mid 40s might predict risk of developing advanced prostate cancer 30 years later.
Sufferers reluctant to tell partners and physicians To view the Social Media Release, click here: http://smr.newswire.ca/en/graceway-pharmaceuticals/genital-warts-emotional-stigma TORONTO, May 17 /PRNewswire/ - Genital warts, caused by the Human Papilloma Virus (HPV) is often the silent part of HPV kept behind closed doors.(i) While HPV prevention is openly discussed, for the more than 300,000 Canadians already living with genital warts,(ii) prevention for them is 'too little, too...
Researchers from Boston University School of Medicine (BUSM), along with clinicians from Boston Medical Center (BMC), have found gastroenterologist knowledge of the appropriate immunizations to recommend to the inflammatory bowel disease (IBD) patient is limited.
WOONSOCKET, R.I., April 25, 2011 /PRNewswire/ -- MinuteClinic, the largest provider of retail-based medical clinics in the United States, has expanded its suite of accessible and affordable health care services to include Vitamin B-12 injections and the Human Papillomavirus (HPV) vaccination (GARDASILÂ®). "There is an increasing medical need for patients to gain more convenient access to B-12 injections and HPV vaccinations," said Nancy Gagliano, M.D., MinuteClinic chief medical officer.
BASEL, Switzerland, April 20, 2011 /PRNewswire-USNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved the cobas HPV (Human Papillomavirus) Test which identifies women at highest risk for developing cervical cancer.
Administration of human papillomavirus (HPV) vaccine doses over a longer period of time to adolescent girls in Vietnam resulted in antibody concentration levels that were comparable to the standard vaccine schedule, according to a new study.
Administration of human papillomavirus (HPV) vaccine doses over a longer period of time to adolescent girls in Vietnam resulted in antibody concentration levels that were comparable to the standard vaccine schedule.
Most women are infected with human papillomavirus (HPV), which can cause cervical cancer - yet few develop the cancer.
A human papillomavirus (HPV), a member of the papillomavirus family, is capable of infecting humans. HPVs establish productive infections in the skin or mucous membranes. Most of the 200 known types cause no symptoms in most people. Some types can cause warts, while others can lead to cancer. There are more than 30 to 40 types of HPV that are typically transmitted through sexual contact and infect the anogenital region. High risk HPV, can lead to cancer, in fact HPV infection is a cause of...
- Sleep; the state or condition of being asleep.
- The state or condition of numbness of a part due to pressure on a nerve: as, the obdormition of a limb.